Propanc Biopharma, Inc. (PPCB)
OTCMKTS
· Delayed Price · Currency is USD
2.500
+0.250 (11.11%)
Jun 3, 2025, 9:53 AM EDT
Propanc Biopharma Market Cap
Propanc Biopharma has a market cap or net worth of $29.03 million as of June 3, 2025. Its market cap has increased by 10,224.37% in one year.
Market Cap
29.03M
Enterprise Value
30.23M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$2.50
Market Cap Chart
Since February 14, 2022, Propanc Biopharma's market cap has increased from 1.26M to 29.03M, an increase of 2,208.53%. That is a compound annual growth rate of 159.62%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
May 30, 2025 | 26.13M | 15,655.94% |
Dec 31, 2024 | 165.82K | -50.41% |
Dec 29, 2023 | 334.41K | -33.52% |
Dec 30, 2022 | 502.99K | -60.00% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Endo Inc. | 1.60B |
Veradigm | 730.27M |
Nika Pharmaceuticals | 667.06M |
Tian'an Technology Group | 614.49M |
Elite Pharmaceuticals | 570.72M |
Glass House Brands | 460.36M |
CytoDyn | 430.80M |
Northwest Biotherapeutics | 392.36M |